Literature DB >> 11487517

Functional characterization of coronary vascular adenosine receptors in the mouse.

A Flood1, J P Headrick.   

Abstract

Coronary responses to adenosine agonists were assessed in perfused mouse and rat hearts. The roles of nitric oxide (NO) and ATP-dependent K(+) channels (K(ATP)) were studied in the mouse. Resting coronary resistance was lower in mouse vs rat, as was minimal resistance (2.2+/-0.1 vs 3.8+/-0.2 mmHg ml(-1) min(-1) g(-1)). Peak hyperaemic flow after 20 - 60 s occlusion was greater in mouse. Adenosine agonists induced coronary dilation in mouse, with pEC(50)s of 9.4+/-0.1 for 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethyl carboxamidoadenosine (CGS21680, A(2A)-selective agonist), 9.3+/-0.1 for 5'-N-ethylcarboxamidoadenosine (NECA, A(1)/A(2) agonist), 8.4+/-0.1 for 2-chloroadenosine (A(1)/A(2) agonist), 7.7+/-0.1 for N(6)-(R)-(phenylisopropyl)adenosine (R-PIA, A(1)/A(2B) selective), and 6.8+/-0.2 for adenosine. The potency order (CGS21680=NECA>2-chloroadenosine>R-PIA>adenosine) supports A(2A) adenosine receptor-mediated dilation in mouse coronary vessels. 0.2 - 2 microM of the A(2B)-selective antagonist alloxazine failed to alter CGS21680 or 2-chloroadenosine responses. pEC(50)s in rat were 6.7+/-0.2 for CGS21680, 7.3+/-0.1 for NECA, 7.6+/-0.1 for 2-chloroadenosine, 7.2+/-0.1 for R-PIA, and 6.2+/-0.1 for adenosine (2-chloroadenosine>NECA=R-PIA>CGS21680> adenosine), supporting an A(2B) adenosine receptor response. NO-synthase antagonism with 50 microM N(G)-nitro L-arginine (L-NOARG) increased resistance by approximately 25%, and inhibited responses to CGS21680 (pEC(50)=9.0+/-0.1), 2-chloroadenosine (pEC(50)=7.3+/-0.2) and endothelial-dependent ADP, but not sodium nitroprusside (SNP). K(ATP) channel blockade with 5 microM glibenclamide increased resistance by approximately 80% and inhibited responses to CGS21680 in control (pEC(50)=8.3+/-0.1) and L-NOARG-treated hearts (pEC(50)=7.3+/-0.1), and to 2-chloroadenosine in control (pEC(50)=6.7+/-0.1) and L-NOARG-treated hearts (pEC(50)=5.9+/-0.2). In summary, mouse coronary vessels are more sensitive to adenosine than rat vessels. A(2A) adenosine receptors mediate dilation in mouse coronary vessels vs A(2B) receptors in rat. Responses in the mouse involve a sensitive NO-dependent response and K(ATP)-dependent dilation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487517      PMCID: PMC1572876          DOI: 10.1038/sj.bjp.0704170

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Relative responses to luminal and adventitial adenosine in perfused arteries.

Authors:  J P Headrick; F J Northington; M R Hynes; G P Matherne; R M Berne
Journal:  Am J Physiol       Date:  1992-11

Review 2.  Cardiovascular purinoceptors.

Authors:  R A Olsson; J D Pearson
Journal:  Physiol Rev       Date:  1990-07       Impact factor: 37.312

3.  Evidence that A2 purinoceptors are involved in endothelium-dependent relaxation of the rat thoracic aorta.

Authors:  R B Rose'Meyer; W Hope
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

4.  Evidence for the involvement of cyclic GMP in adenosine-induced, age-dependent vasodilatation.

Authors:  H Moritoki; T Matsugi; H Takase; H Ueda; A Tanioka
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

5.  Different endothelial mechanisms involved in coronary responses to known vasodilators.

Authors:  B Leipert; B F Becker; E Gerlach
Journal:  Am J Physiol       Date:  1992-06

6.  Coronary vasodilation to acetylcholine, adenosine and bradykinin in dogs: effects of inhibition of NO-synthesis and captopril.

Authors:  J Zanzinger; E Bassenge
Journal:  Eur Heart J       Date:  1993-11       Impact factor: 29.983

7.  Relaxation by adenosine and its analogs of potassium-contracted human coronary arteries.

Authors:  M H Sabouni; M V Ramagopal; S J Mustafa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-04       Impact factor: 3.000

8.  Functional characterization of three adenosine receptor types.

Authors:  M F Gurden; J Coates; F Ellis; B Evans; M Foster; E Hornby; I Kennedy; D P Martin; P Strong; C J Vardey
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

9.  A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.

Authors:  A Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts.

Authors:  L E Brackett; J W Daly
Journal:  Biochem Pharmacol       Date:  1994-03-02       Impact factor: 5.858

View more
  19 in total

1.  Contributions of A2A and A2B adenosine receptors in coronary flow responses in relation to the KATP channel using A2B and A2A/2B double-knockout mice.

Authors:  Maryam Sharifi Sanjani; Bunyen Teng; Thomas Krahn; Stephen Tilley; Catherine Ledent; S Jamal Mustafa
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-23       Impact factor: 4.733

2.  Differential coronary microvascular exchange responses to adenosine: roles of receptor and microvessel subtypes.

Authors:  Jianjie Wang; Stevan P Whitt; Leona J Rubin; Virginia H Huxley
Journal:  Microcirculation       Date:  2005-06       Impact factor: 2.628

3.  Contribution of adenosine A(2A) and A(2B) receptors to ischemic coronary dilation: role of K(V) and K(ATP) channels.

Authors:  Zachary C Berwick; Gregory A Payne; Brandon Lynch; Gregory M Dick; Michael Sturek; Johnathan D Tune
Journal:  Microcirculation       Date:  2010-11       Impact factor: 2.628

Review 4.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

5.  Mediators of coronary reactive hyperaemia in isolated mouse heart.

Authors:  Amanda J Zatta; John P Headrick
Journal:  Br J Pharmacol       Date:  2005-02       Impact factor: 8.739

6.  Aldosterone impairs coronary adenosine-mediated vasodilation via reduced functional expression of Ca2+-activated K+ channels.

Authors:  Maloree Khan; Alex I Meuth; Scott M Brown; Bysani Chandrasekar; Douglas K Bowles; Shawn B Bender
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-06-14       Impact factor: 4.733

7.  Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts.

Authors:  Zhichao Zhou; Uthra Rajamani; Hicham Labazi; Stephen L Tilley; Catherine Ledent; Bunyen Teng; S Jamal Mustafa
Journal:  Purinergic Signal       Date:  2015-04-25       Impact factor: 3.765

8.  Contractile effects of adenosine, coronary flow and perfusion pressure in murine myocardium.

Authors:  Laura Willems; John P Headrick
Journal:  Pflugers Arch       Date:  2006-10-28       Impact factor: 3.657

9.  Adenosine A2A receptor signaling regulation of cardiac NADPH oxidase activity.

Authors:  David Ribé; David Sawbridge; Sapna Thakur; Martin Hussey; Catherine Ledent; Ian Kitchen; Susanna Hourani; Jian-Mei Li
Journal:  Free Radic Biol Med       Date:  2008-01-05       Impact factor: 7.376

10.  Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice.

Authors:  Hicham Labazi; Bunyen Teng; Zhichao Zhou; S Jamal Mustafa
Journal:  J Mol Cell Cardiol       Date:  2015-12-02       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.